Audited Financial Results for the quarter ended on 31-03-2025
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has filed its audited financial results for the quarter and year ended March 31, 2025 on NSE. The actual financial figures, key line items (revenue, profit after tax, EBITDA), and any auditor observations are not included in the provided announcement text, so specific numbers cannot be reported. Based solely on the headline, this is a routine quarterly/annual results disclosure required of listed companies. No detail on auditor's opinion type, exceptional items, related-party transactions, debt levels, or cash flows is available in the supplied content.
Without the actual numbers or auditor commentary in the filing text, no meaningful impact on shareholders or the stock price can be assessed. Investors should read the full audited results document for revenue, PAT, margins, and any auditor qualifications before drawing conclusions.